Imovax Polio Special Precautions

Take special care with IMOVAX POLIO if the patient: Has blood disorders such as decrease in platelets (thrombocytopenia) or clotting disorders because of the risk of bleeding which may occur during intramuscular administration of the vaccine.
Is taking a treatment that suppresses the immune defences (corticosteroid drugs, cytotoxic drugs, radiotherapy or any other treatments likely to weaken the immune defences) or if the patient presents with an immune deficiency (immunosuppression), the immune response to the vaccine may be reduced. In such cases it is recommended to postpone vaccination until the end of the treatment or to make sure the subject is well protected.
Present with chronic immunodeficiency such as an infection with the AIDS virus (HIV). Vaccination is recommended even if the immune response may be limited.
Vaccination may also be recommended for subjects in whom the oral vaccine is contraindicated, and as a booster for subjects previously vaccinated with the oral vaccine.
Fainting can occur following, or even before, any needle injection. Also, inform the doctor or nurse if the patient has fainted during a previous injection.
If with doubts, talk to the doctor or pharmacist.
IMOVAX POLIO, contains phenylalanine, ethanol and sodium: IMOVAX POLIO contains 12.5 micrograms of phenylalanine in each dose of 0.5 mL. Phenylalanine may be dangerous for patients with phenylketonuria (PKU), a rare genetic disorder characterised by the accumulation of phenylalanine that cannot be correctly eliminated.
IMOVAX POLIO contains 2 mg alcohol (ethanol) in a dose of 0.5 mL. The low quantity of alcohol contained in this medicinal product is unlikely to cause a notable effect.
IMOVAX POLIO contains less than 1 mmol (23 mg) sodium per dose, i.e. it is essentially "sodium-free".
Driving and Using Machines: This vaccine is unlikely to have any effects on the ability to drive or to use machines. However, no studies on this topic were performed.